Search by Drug Name or NDC
NDC 00641-6150-25 Neostigmine Methylsulfate 0.5 mg/mL Details
Neostigmine Methylsulfate 0.5 mg/mL
Neostigmine Methylsulfate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is NEOSTIGMINE METHYLSULFATE.
Product Information
| NDC | 00641-6150 |
|---|---|
| Product ID | 0641-6150_96273a3a-996b-4efa-9289-594fcc41c85f |
| Associated GPIs | 76000040202017 |
| GCN Sequence Number | 071070 |
| GCN Sequence Number Description | neostigmine methylsulfate VIAL 0.5 MG/ML INTRAVEN |
| HIC3 | J1B |
| HIC3 Description | CHOLINESTERASE INHIBITORS |
| GCN | 34758 |
| HICL Sequence Number | 001988 |
| HICL Sequence Number Description | NEOSTIGMINE METHYLSULFATE |
| Brand/Generic | Generic |
| Proprietary Name | Neostigmine Methylsulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Neostigmine Methylsulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | NEOSTIGMINE METHYLSULFATE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207042 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00641-6150-25 (00641615025)
| NDC Package Code | 0641-6150-25 |
|---|---|
| Billing NDC | 00641615025 |
| Package | 25 VIAL, MULTI-DOSE in 1 CARTON (0641-6150-25) / 10 mL in 1 VIAL, MULTI-DOSE (0641-6150-01) |
| Marketing Start Date | 2015-12-28 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |